Recent Finacing
Recent Raise
Permeon Biologics develops intracellular biologics using its Intraphilin platform to deliver supercharged proteins—directly or via covalent conjugation/complexing with proteins and nucleic acids—to create non‑cytotoxic intracellular therapeutics.
Focus Areas
Total Raised
Funding round